Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.ganeshremedies.com | |
Market Cap | 797.30 Cr. | |
Enterprise Value(EV) | 835.49 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 17.10 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 36.29 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.18 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 81.58 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 7.61 | Calculated using Price: 620.60 |
Dividend Yield | 0.08 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.28 Cr. | 12,847,198 Shares |
FaceValue | 10 | |
About Shree Ganesh Remedies Ltd. | ||
The company is as ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. |
1 Day |
|
-1.59% |
1 Week |
|
+1.69% |
1 Month |
|
-8.57% |
3 Month |
|
-10.45% |
6 Month |
|
+27.04% |
1 Year |
|
+104.08% |
2 Year |
|
+92.73% |
5 Year |
|
+1305.03% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 10.38 | 8.06 | 17.31 | 20.75 | 19.95 | 25.35 | 21.18 | 24.02 | 22.62 | |
Return on Capital Employed (%) | 16.15 | 12.42 | 26.15 | 27.68 | 27.04 | 32.63 | 27.51 | 32.47 | 24.67 | |
Return on Assets (%) | 8.56 | 7.01 | 14.34 | 16.52 | 16.2 | 20.56 | 17.29 | 19.47 | 15.42 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 13 | 14 | 17 | 29 | 34 | 42 | 50 | 62 | 89 | 100 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 31 | 33 | |
Curr. Liab. | 2 | 2 | 4 | 7 | 7 | 10 | 10 | 15 | 24 | 23 | |
Minority Int. | |||||||||||
Equity & Liab. | 15 | 16 | 21 | 36 | 41 | 52 | 61 | 77 | 144 | 156 | |
Non Curr. Assets | 5 | 5 | 5 | 7 | 16 | 17 | 23 | 32 | 79 | 89 | |
Curr. Assets | 10 | 11 | 17 | 28 | 26 | 35 | 38 | 45 | 64 | 67 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 15 | 16 | 21 | 36 | 41 | 52 | 61 | 77 | 144 | 156 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 17 | 16 | 20 | 27 | 35 | 58 | 49 | 71 | 90 | 117 | |
Other Income | 0 | 0 | 0 | 2 | 1 | 4 | 2 | 4 | 3 | 3 | |
Total Income | 17 | 16 | 20 | 29 | 36 | 63 | 51 | 75 | 93 | 121 | |
Total Expenditure | -14 | -14 | -16 | -22 | -27 | -47 | -35 | -53 | -67 | -85 | |
PBIDT | 3 | 2 | 5 | 7 | 10 | 15 | 16 | 21 | 26 | 36 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -2 | -3 | -3 | -4 | -5 | |
Taxation | -1 | -1 | -1 | -2 | -2 | -3 | -3 | -5 | -6 | -8 | |
Exceptional Items | |||||||||||
PAT | 1 | 1 | 3 | 5 | 6 | 10 | 10 | 13 | 17 | 22 | |
Adjusted EPS | 1 | 1 | 3 | 4 | 5 | 8 | 8 | 11 | 14 | 18 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | -5 | 4 | 3 | 13 | 17 | |||||
Cash Fr. Inv. | -3 | 0 | -3 | -1 | -12 | -54 | |||||
Cash Fr. Finan. | 8 | 0 | 0 | -1 | -1 | 41 | |||||
Net Change | 4 | -5 | 1 | 2 | 0 | 5 | |||||
Cash & Cash Eqvt | 6 | 1 | 2 | 3 | 4 | 9 |
Wed, 17 Apr 2024
Commencement Of Trial Run. Commencement of Trial Run |
Fri, 05 Apr 2024
Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended On March 31 2024 Compliance Certificate Pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the year ended on March 31 2024 |
Fri, 05 Apr 2024
Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Year Ended On March 31 2024. Certificate under Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for year ended on March 31 2024. |
Mon, 29 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
High Decrease in 1 Month |
High Increase in 6 Months |